Verona Pharma

NASDAQ: VRNA · Real-Time Price · USD
105.26
-0.01 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
105.27
0.01%
After-hours: Aug 15, 2025, 04:15 PM EDT

Verona Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
399.76M 271.77M 227.83M 148.38M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a 15M 15M 15M
Other Long-Term Assets
16.97M n/a 15.07M 15.08M
Receivables
37.26M 10.95M 9.28M 15.58M
Inventory
6.25M n/a 2.5M 4.04M
Other Current Assets
2.73M 3.37M 3.39M 2.06M
Total Current Assets
453.57M 289.71M 243M 170.06M
Property-Plant & Equipment
3.15M 2.87M 927K 979K
Goodwill & Intangibles
545K 545K 545K 545K
Total Long-Term Assets
20.67M 18.42M 16.47M 16.52M
Total Assets
474.24M 308.12M 259.47M 186.59M
Account Payables
11.27M 3.49M 2.91M 10.04M
Deferred Revenue
n/a n/a n/a 22.4M
Short-Term Debt
1.12M n/a n/a n/a
Other Current Liabilities
3.55M 435K 1.41M 327K
Total Current Liabilities
42.68M 8.69M 19.03M 33.42M
Long-Term Debt
120.34M 48.37M 9.77M 4.87M
Other Long-Term Liabilities
105.42M n/a n/a n/a
Total Long-Term Liabilities
227M 50.15M 9.97M 5.16M
Total Liabilities
269.68M 58.84M 29M 38.58M
Total Debt
122.7M 51.33M 10.65M 5.81M
Common Stock
43.36M 42.77M 40.53M 31.86M
Retained Earnings
-562.4M -388.43M -333.1M -263.72M
Comprehensive Income
-4.6M -4.6M -4.6M -4.6M
Shareholders Equity
204.56M 249.28M 230.47M 148M
Total Investments
15M 15M 15M 15M